SAB Biotherapeutics, Inc. (SABS)
NASDAQ: SABS · Real-Time Price · USD
4.040
+0.040 (1.00%)
At close: Jan 23, 2026, 4:00 PM EST
4.120
+0.080 (1.98%)
After-hours: Jan 23, 2026, 7:47 PM EST
SAB Biotherapeutics Employees
SAB Biotherapeutics had 63 employees as of December 31, 2024. The number of employees increased by 6 or 10.53% compared to the previous year.
Employees
63
Change (1Y)
6
Growth (1Y)
10.53%
Revenue / Employee
$1,821
Profits / Employee
-$68,064
Market Cap
192.33M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2024 | 63 | 6 | 10.53% |
| Dec 31, 2023 | 57 | 1 | 1.79% |
| Dec 31, 2022 | 56 | -83 | -59.71% |
| Dec 31, 2021 | 139 | 53 | 61.63% |
| Dec 31, 2020 | 86 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Coherus Oncology | 228 |
| ProQR Therapeutics | 166 |
| Century Therapeutics | 150 |
| Prelude Therapeutics | 131 |
| Compugen | 74 |
| Cartesian Therapeutics | 66 |
| Quince Therapeutics | 36 |
| Cardiff Oncology | 33 |
SABS News
- 16 days ago - SAB BIO Strengthens Board of Directors with Appointment of New Chair and New Director - GlobeNewsWire
- 17 days ago - SAB BIO to Present at the 44th Annual J.P. Morgan Healthcare Conference - GlobeNewsWire
- 5 weeks ago - First Patient Dosed in SAB BIO's SAFEGUARD Clinical Trial of SAB-142 for the Treatment of Stage 3 T1D - GlobeNewsWire
- 5 weeks ago - SAB BIO Announces Positive Confirmatory Clinical Results from the Phase 1 Study of SAB-142 in Development for the Treatment of Stage 3 T1D - GlobeNewsWire
- 6 weeks ago - SAB BIO to Present Data Showcasing Progress in the Development of SAB-142 at the Asian Conference on Innovative Therapies for Diabetes Management - GlobeNewsWire
- 2 months ago - SAB BIO Reports Third Quarter Financial Results and Recent Business Highlights - GlobeNewsWire
- 2 months ago - SAB BIO to Present Data at the International Society for Pediatric and Adolescent Diabetes Annual Conference Showcasing Progress in the Development of SAB-142 - GlobeNewsWire
- 2 months ago - SAB BIO to Participate in Upcoming Investor Conferences - GlobeNewsWire